June 26, 2024 The Neuro (Montreal Neurological Institute-Hospital) at McGill University Selects Cubresa’s BrainPET for 7T Brain Research Program Winnipeg, MB – June 26, 2024 – The Neuro (Montreal Neurological Institute-Hospital) at McGill University has selected Cubresa’s investigational BrainPET scanner to enhance their 7T MRI research program. This will be the first installation into a…
Tuesday, May 30th, 2023 PRESS RELEASE Cubresa Installs First BrainPET Insert System at Lawson Health Research Institute Winnipeg, MB – May 30th, 2023 – Cubresa has installed the first BrainPET Insert System at St. Joseph’s Health Care London, in partnership with the hospital’s research institute – Lawson Health Research Institute. The Cubresa BrainPET is a…
Wednesday, February 16th, 2022 PRESS RELEASE Case Western Reserve University selects Cubresa’s NuPET™ System to Support Preclinical Research Activities Winnipeg, MB – February 16th, 2022 – Case Western Reserve University (CWRU) has selected Cubresa’s Preclinical NuPET™ Insert System to add to their suite of imaging tools. The NuPET 66 will support research in a wide…
Barrow Neurological Institute selects Cubresa’s BrainPET system to support neurological research activities Winnipeg, MB – January 5th, 2022 – Barrow Neurological Institute, the world’s largest neurological disease treatment and research institution, in conjunction with Arizona State University (ASU), have selected Cubresa’s BrainPET system to add to their suite of imaging tools. A joint acquisition between Barrow…
Wednesday, October 20th, 2021 PRESS RELEASE Cubresa Enters into BrainPET Technology License Agreement with the Sino Canadian Health Institute Winnipeg, MB – October 20th, 2021 – Cubresa Inc., a world leader in the design and development of PET Insert systems for MRI, and the Sino Canadian Health Institute (SCHI), a Canadian based wholly owned subsidiary of…
Monday, September 20, 2021 PRESS RELEASE Cubresa enters into Memorandum of Understanding with the University of California, Davis Winnipeg, MB – September 20th, 2021 – Cubresa Inc., a world leader in the design and development of PET insert systems for MRI, has entered into a Memorandum of Understanding (MOU) with the University of California, Davis. The MOU provides a mechanism to identify and potentially pursue specific technical and application-focused research projects related to Alzheimer’s Disease…
Tuesday, November 2nd, 2020 PRESS RELEASE NuPET Bio BSL3 Imaging System Selected by Innovative Solutions Canada to test in COVID-19 Research Program Winnipeg, MB – Cubresa Inc. is pleased to announce that its NuPET Bio imaging system, the first in the world specifically designed for infectious disease research in BSL3 environments, has received a contract…
Cubresa is pleased to be featured in Dotmed’s Health Care Business News Magazine – June 2020 edition. The article, found on page 56, focuses on innovation in the PET and SPECT markets. Dr. James Schellenberg, Cubresa’s Founder and CEO is pleased to share information highlighting the value of its NuPET preclinical insert for SARS-CoV-2 research…
Cubresa Inc., a world leader in PET inserts for MRI, is pleased to announce that the Sino-Canadian Health Engineering Research Institute (SCHERI) of Hefei, Anhui province, China, has purchased Cubresa’s preclinical NuPET6620™ scanner. This marks Cubresa’s first sale of its NuPET system into the Chinese marketplace. “Cubresa’s NuPET6620 system is an integral component of a…
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
About Us
Leadership
Technology
Careers
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4